All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.

The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Jordi Esteve | EHA 2018 | New therapeutic targets for leukemia stem cells in AML

Featured
Jun 20, 2018
Share:

23rd Congress of European Hematology Association, 14-17 June 2018, Stockholm, Sweden

Jordi Esteve: Hospital Clinic of Barcelona, Barcelona, ES

Interview topic: New therapeutic targets for leukemia stem cells in AML

Jordi Esteve | EHA 2018 | New therapeutic targets for leukemia stem cells in AML

Share:

Your opinion matters

How would you treat relapsed AML patients following ven+aza based therapy?
4 votes - 8 hours left ...

Newsletter

Subscribe to get the best content related to AML delivered to your inbox